SequelSEC

Teladoc Health, Inc. TDOC

Services-Offices & Clinics of Doctors of Medicine · CIK 0001477449 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$2.47B
Fiscal year ended 2026-09-30
Operating income
-$162.96M
Fiscal year ended 2026-09-30
Free cash flow
$261.96M
Fiscal year ended 2026-09-30

Valuation, from the filing

Public float$1.53BMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$8.59Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Offices & Clinics of Doctors of Medicine filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue0.4%0th
Current ratio2.77x86th
Operating margin-10.4%14th
FCF margin11.3%75th
Net margin-7.9%43th
Revenue YoY growth-1.5%43th
SBC / revenue3.2%43th

Teladoc Health, Inc. (TDOC) reported revenue of $2.47B and net income of -$154.82M for the fiscal year ended 2026-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Teladoc Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.

Income

Teladoc Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Revenue$2.47B
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$162.96M
Net income-$154.82M
Research & development$267.88M
Weighted-average diluted sharesUnavailable
Pretax income-$158.65M
Income tax expense-$3.83M
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$421.94M
Selling & marketingUnavailable

Balance

Teladoc Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Cash & equivalents$849.91M
Total assets$2.78B
Current assets$1.23B
Total liabilities$1.48B
Current liabilities$1.42B
Total equity incl. NCI$1.29B
Temporary (mezzanine) equityUnavailable
Inventory$30.75M
Accounts receivable$230.95M
Goodwill$283.19M
Long-term debtUnavailable
Accounts payable$46.34M

Cash flow

Teladoc Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Operating cash flow$268.38M
Capital expenditures$6.42M
Investing cash flow-$143.25M
Financing cash flow-$53.00K
Net change in cashUnavailable
Stock-based compensation$51.44M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Teladoc Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-30
Free cash flow$261.96M
Gross marginUnavailable
Operating margin-6.6%
FCF margin10.6%
SBC / revenue2.1%
Current ratio0.87x
Revenue YoY growth-2.4%
Net margin-6.3%
R&D / revenue10.9%
CapEx / revenue0.3%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TDOC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-29View SEC filing
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-07-30View SEC filing

Companies in the same industry

AIRS CDIX HIMS HLYK LFMD SBC STLN

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.